Partial epilepsy with antecedent febrile seizures and seizure aggravation by antiepileptic drugs: Associated with loss of function of Nav1.1-Reference-Cited by-同舟云学术

Partial epilepsy with antecedent febrile seizures and seizure aggravation by antiepileptic drugs: Associated with loss of function of Nav1.1

Published:2010-06-07 Issue:9 Volume:51 Page:1669-1678
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:

Author:

Liao Wei-Ping,Shi Yi-Wu,Long Yue-Sheng,Zeng Yang,Li Tian,Yu Mei-Juan,Su Tao,Deng Ping,Lei Zhi-Gang,Xu Shu-Jun,Deng Wei-Yi,Liu Xiao-Rong,Sun Wei-Wen,Yi Yong-Hong,Xu Zao C.,Duan Shumin

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1528-1167.2010.02645.x/fullpdf

Reference42 articles.

1. Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation;Abou-Khalil;Neurology,2001

2. Fever, genes, and epilepsy;Baulac;Lancet Neurol,2004

3. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels;Catterall;Neuron,2000

4. Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+ channel;Cestele;J Neurosci,2008

5. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy;Ceulemans;Pediatr Neurol,2004

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into clinical phenotypes and treatment responses in a Small cohort of Taiwanese patients with SCN1A variants: A Preliminary study;Pediatrics & Neonatology;2024-08

2. SCN1A—Characterization of the Gene’s Variants in the Polish Cohort of Patients with Dravet Syndrome: One Center Experience;Current Issues in Molecular Biology;2024-05-07

3. Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan;Expert Review of Neurotherapeutics;2024-03

4. Genetic Dependence and Genetic Diseases;2023-08-05

5. Use of Sodium Channel Blockers in the Thr226Met Pathologic Variant of SCN1A: A Case Report;Neuropediatrics;2023-07-19